This company has shut down. Vigil Neuroscience is no longer operating — its last tracked round was a Post-IPO Equity in 2024.
Explore the Startup GraveyardVigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Vigil Neuroscience has raised $40.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2024.
Vigil Neuroscience's investors include Cormorant Asset Management, Sanofi, OrbiMed, Hatteras Venture Partners, Vida Ventures.
Vigil Neuroscience is headquartered in Cambridge, United States.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Vigil Neuroscience is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vigil Neuroscience — Funding & Investors." VCBacked, June 27, 2024, https://www.vcbacked.co/company/vigil-neuroscience. Accessed July 19, 2026.
VCBacked. (2024). Vigil Neuroscience — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/vigil-neuroscience
{{cite web |title=Vigil Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/vigil-neuroscience |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated